Photo of Dorna Jafari from X
Jun 29, 2024, 11:05
Neoadjuvant botensilimab and balstilimab in colorectal cancer
Smitha Krishnamurthi, Gastrointestinal medical oncologist at Cleveland Clinic, shared on X:
“Neoadjuvant botensilimab (1 dose) and balstilimab (4 doses) resulted in pathologic complete response in 5/9 patients with pMMR colorectal cancer!
Early results but super impressive.”
Source: Smitha Krishnamurthi/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 06:23
Mar 29, 2025, 06:05
Mar 29, 2025, 04:55
Mar 29, 2025, 04:16
Mar 28, 2025, 20:11
Mar 28, 2025, 19:58
Mar 28, 2025, 19:38